Industry Raises Concerns Over Australian ‘Boxed Warning’ Proposals
Executive Summary
Stakeholders have generally welcomed draft Australian guidance on boxed warnings but concerns have been raised about the impact of using them too frequently and the kind and level of evidence that will be required.
You may also be interested in...
Australia Works On Improving Use Of Boxed Warnings For Prescription Drugs
The Therapeutic Goods Administration has also suggested possible options to ensure boxed warnings are included in all promotional materials issued by sponsors.
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.